FDA approves three fast-track studies of psychedelic drugs to treat PTSD, depression
The FDA did not specify what companies will conduct the research, but two of the companies are studying psilocybin. The third company is studying methylone, which is similar to the psychedelic MDMA, as a possible treatment for PTSD.
Original Source
Read the full article at Justthenews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.